Recent Progress on the Synergistic Antitumor Effect of a Borneol-Modified Nanocarrier Drug Delivery System.

Li, Jinxiu; Xie, Qian; Ma, Rong; Li, Yong; Yuan, Jianmei; Ren, Mihong; Li, Hongyan; Wang, Jiajun; Lu, Danni; Xu, Zhuo; Wang, Jian

Li, Jinxiu; Xie, Qian; Ma, Rong; Li, Yong; Yuan, Jianmei; Ren, Mihong; Li, Hongyan; Wang, Jiajun; Lu, Danni; Xu, Zhuo; Wang, Jian.

Afiliação

Li J; State Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu, China.
Xie Q; College of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Ma R; State Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu, China.
Li Y; College of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Yuan J; State Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu, China.
Ren M; College of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Li H; State Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu, China.
Wang J; College of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Lu D; State Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu, China.
Xu Z; College of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Wang J; State Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu, China.

Front Med (Lausanne) ; 8: 750170, 2021.

Article em En | MEDLINE | ID: mdl-34901063

Palavras-chave

borneol; drug delivery; drug resistance; nanocarrier; targeting; tumor therapy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Med (Lausanne) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google